Healthcare Quality Management Market - Global Forecast To 2030
商品番号 : SMB-89045
| 出版社 | MarketsandMarkets |
| 出版年月 | 2025年10月 |
| ページ数 | 355 |
| 図表数 | 435 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | USD 4,950 |
| 種別 | 英文調査報告書 |
医療向け品質マネジメントシステム（QMS）市場 – オファリング[ソフトウェア（統合型）、サービス]、機能（コンプライアンス、リスク、監査、CAPA、変更）、ユースケース（品質、分析、パフォーマンス、規制）、エンドユーザー（病院、ASC、支払者） – 2030年までの世界予測
世界の医療向け品質マネジメントシステム（QMS）市場は、2025年の14億2,000万米ドルから2030年には25億1,000万米ドルに達し、予測期間中に12.1%の高いCAGR（年平均成長率）で成長すると予測されています。医療向け品質マネジメントシステム（QMS）市場は、患者の安全、臨床品質、そして成果の透明性への関心の高まりを背景に、着実に成長を続けています。医療水準の向上を目指す規制要件の強化や政府の取り組みにより、医療提供者は構造化された品質管理ソリューションの導入を迫られています。これらのシステムにより、病院や医療機関はパフォーマンス指標の追跡、リスク管理、コンプライアンスの確保、報告プロセスの合理化が可能になります。しかし、導入を後押しする強力な要因があるにもかかわらず、この分野は根強い課題に直面しています。中でも、シームレスな統合と洞察の創出を阻害する、多様な医療ITシステム間のデータ品質と断片化、そして品質管理プラットフォームの導入・維持コストの高さが挙げられます。これらの障壁に対処することは、市場がより安全で効率的、そして説明責任のある医療提供という約束を果たす上で不可欠です。
本レポートは、医療向け品質マネジメントシステム（QMS）市場を分析し、提供内容、機能、ユースケース、エンドユーザー、地域に基づいて、様々な市場セグメントの市場規模と将来の成長可能性を推定することを目的としています。また、この市場で活動する主要企業の競合分析に加え、各社の企業概要、製品ラインナップ、最近の動向、主要な市場戦略についても提供しています。
本レポートは、既存企業だけでなく新規参入企業や小規模企業にとっても、市場の動向を把握し、ひいては市場シェアの拡大に繋がる有益な情報となります。本レポートをご購入いただいた企業は、以下の戦略のいずれか、あるいは組み合わせて活用することで、市場における自社の地位を強化することができます。
Report Description
The global healthcare quality management (QMS) market is projected to reach USD 2.51 billion by 2030 from USD 1.42 billion in 2025, at a high CAGR of 12.1% during the forecast period. The healthcare quality management (QMS) market is progressing steadily, driven by the growing emphasis on patient safety, clinical quality, and outcome transparency. Rising regulatory requirements and government initiatives aimed at improving care standards are pushing providers to adopt structured quality management solutions. These systems enable hospitals and healthcare organizations to track performance metrics, manage risks, ensure compliance, and streamline reporting processes. However, despite strong adoption drivers, the sector faces persistent challenges. Chief among them are data quality and fragmentation across diverse healthcare IT systems, which hinder seamless integration and insights generation, along with the high implementation and maintenance costs of quality management platforms. Addressing these barriers will be crucial for the market to deliver on its promise of safer, more efficient, and accountable healthcare delivery.
“By use case, the business intelligence & analytics segment is the largest segment during the forecast period.”
The business intelligence (BI) & analytics segment accounts for the largest share of the healthcare quality management (QMS) market and is projected to maintain its lead in the coming years. This dominance is driven by the increasing need for data-driven decision-making, predictive insights, and performance optimization in healthcare organizations. BI and analytics solutions enable providers, payers, and administrators to analyze clinical, financial, and operational data in real time, supporting proactive quality improvement and regulatory compliance. By leveraging advanced analytics, healthcare institutions can identify care gaps, monitor patient outcomes, and streamline resource allocation, ultimately improving both efficiency and patient safety. The growing adoption of value-based care models and the shift toward personalized medicine further strengthen demand for BI-driven insights. Moreover, integration with cloud platforms and interoperability across diverse health IT systems enhances scalability and collaboration. As healthcare stakeholders continue to prioritize measurable quality outcomes and cost optimization, BI & analytics will remain the cornerstone use case, reinforcing its market leadership.
“By offering, the software segment is expected to register the fastest growth in the healthcare quality management (QMS) market during the forecast period.”
The software segment is expected to register the fastest growth in the healthcare quality management (QMS) market during the forecast period. This growth is driven by the rising demand for scalable, specialized, and flexible solutions that streamline quality management functions such as compliance reporting, risk assessment, incident tracking, performance monitoring, and patient safety management. Software solutions help healthcare organizations automate workflows, reduce administrative burden, and provide real-time visibility into quality metrics, enabling data-driven decision-making across departments. By centralizing and standardizing processes, these solutions minimize errors and ensure alignment with evolving regulatory requirements. The increasing adoption of cloud-based platforms, integration with EHRs, and advanced analytics capabilities are further accelerating software deployment. As healthcare providers focus on improving care quality, operational efficiency, and regulatory compliance, software offerings are poised to drive significant growth in the market over the forecast period.
“The Asia Pacific is expected to witness the highest growth rate during the forecast period.”
The Asia Pacific region is expected to register the fastest growth in the healthcare quality management (QMS) market over the forecast period. This growth is supported by rising government initiatives to strengthen healthcare systems, increasing investments in digital health technologies, and greater regulatory focus on patient safety and clinical quality. Rapid expansion of healthcare infrastructure, particularly in emerging economies such as India and China, is driving demand for advanced quality management solutions. The region’s growing chronic disease burden and aging population are further accelerating the need for robust platforms to track outcomes, reduce medical errors, and enhance efficiency in care delivery. Additionally, the increasing adoption of cloud-based healthcare IT solutions and growing collaborations between local providers and global technology vendors are enabling faster deployment of integrated quality management systems. Together, these factors position the Asia Pacific as the fastest-growing regional market, playing a pivotal role in shaping the future of healthcare quality management (QMS) worldwide.
In-depth interviews have been conducted with chief executive officers (CEOs), Directors, and other executives from various key organizations operating in the authentication and brand protection marketplace. The breakdown of primary participants is as mentioned below:
- By Company Type: Tier 1 (48%), Tier 2 (36%), and Tier 3 (16%)
- By Designation: Directors (15%), Managers (10%), and Others (75%)
- By Region: North America (39%), Europe (31%), Asia Pacific (21%), Latin America (6%), and the Middle East & Africa (3%)
Key Players in the Healthcare Quality Management (QMS) Market
The key players operating in the healthcare quality management (QMS) market include Nuance Communications, Inc. (US), Premier Inc. (US), Optum, Inc. (US), Intelex Technologies (Canada), DNV (Norway), RLDatix (US), Riskonnect, Inc. (US), HCI (Ireland), Ideagen (UK), Medisolv, Inc. (US), Vālenz Health (US), OdiTek Solutions (India), The Patient Safety Company (TPSC) (Netherlands), MorCare (Harris Health) (US), YouComply, Ltd. (ViClarity) (UK), SimplerQMS (US), NAVEX Global, Inc. (US), ProviderTrust (US), MedTrainer (US), OKKALA SOLUTIONS PRIVATE LIMITED (India), SafeQual (US), Effivity Technologies, Inc. (US), Title21 Health Solutions (US), Medblaze (INFINI) (India), eTaskPro (UAE), Qualityze (US), Karminn Consultancy Network (India), and MEG (Ireland).
Research Coverage:
The report analyzes the healthcare quality management (QMS) market and aims to estimate the market size and future growth potential of various market segments, based on offering, function, use case, end user, and region. The report also provides a competitive analysis of the key players operating in this market, along with their company profiles, product offerings, recent developments, and key market strategies.
Reasons to Buy the Report
This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their positions in the market.
This report provides insights into:
Analysis of key drivers (rising adoption of AI, ML, and predictive analytics in healthcare; increasing focus on patient safety and clinical quality; interoperability of health data & health information exchange; and growing regulatory requirements and government initiatives), restraints (data quality and fragmentation challenges across healthcare IT systems and high implementation and maintenance costs of quality management systems), opportunities (integration with patient-generated health data (PGHD) and voice and NLP for quality documentation), and challenges (data privacy and security concerns, standardization of quality measures & data models, and limited skilled workforce & training gaps) influencing the growth of the healthcare quality management (QMS) market.
- Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the healthcare quality management (QMS) market.
- Market Development: Comprehensive information on the lucrative emerging markets, offering, function, use case, end user, and region.
- Market Diversification: Exhaustive information about the product portfolios, growing geographies, recent developments, and investments in the healthcare quality management (QMS) market
- Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of the leading players in the healthcare quality management (QMS) market, like Nuance Communications, Inc. (US), Premier Inc. (US), Optum, Inc. (US), RLDatix (US), and Intelex Technologies (Canada).
Table of Contents
1 INTRODUCTION 34
1.1 STUDY OBJECTIVES 34
1.2 MARKET DEFINITION 34
1.3 STUDY SCOPE 35
1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE 35
1.3.2 INCLUSIONS & EXCLUSIONS 36
1.3.3 YEARS CONSIDERED 37
1.4 CURRENCY CONSIDERED 37
1.5 LIMITATIONS 38
1.5.1 METHODOLOGY-RELATED LIMITATIONS 38
1.5.2 SCOPE-RELATED LIMITATIONS 38
1.6 MARKET STAKEHOLDERS 38
1.7 SUMMARY OF CHANGES 39
2 RESEARCH METHODOLOGY 40
2.1 RESEARCH APPROACH 40
2.1.1 SECONDARY RESEARCH 40
2.1.1.1 Key data from secondary sources 41
2.1.2 PRIMARY RESEARCH 42
2.1.2.1 Primary sources 42
2.1.2.2 Key data from primary sources 43
2.1.2.3 Breakdown of primaries 43
2.1.2.4 Insights from primary experts 44
2.2 RESEARCH METHODOLOGY DESIGN 44
2.3 MARKET SIZE ESTIMATION 45
2.4 MARKET BREAKDOWN & DATA TRIANGULATION 49
2.5 MARKET SHARE ESTIMATION 49
2.6 STUDY ASSUMPTIONS 50
2.7 RESEARCH LIMITATIONS 50
2.7.1 METHODOLOGY-RELATED LIMITATIONS 50
2.8 RISK ASSESSMENT 50
3 EXECUTIVE SUMMARY 51
4 PREMIUM INSIGHTS 56
4.1 OPPORTUNITIES FOR PLAYERS IN HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET 56
4.2 NORTH AMERICA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY OFFERING & COUNTRY 57
4.3 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 57
4.4 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET: REGIONAL MIX (2023–2030) 58
4.5 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET: DEVELOPED VS. EMERGING ECONOMIES, 2025 VS. 2030 (USD MILLION) 58
5 MARKET OVERVIEW 59
5.1 INTRODUCTION 59
5.2 MARKET DYNAMICS 59
5.2.1 DRIVERS 60
5.2.1.1 Rising adoption of AI, ML, and predictive analytics in healthcare 60
5.2.1.2 Increasing focus on patient safety and clinical quality 62
5.2.1.3 Interoperability of health data & health information exchange 62
5.2.1.4 Growing regulatory requirements and government initiatives 64
5.2.2 RESTRAINTS 65
5.2.2.1 Data quality and fragmentation challenges across healthcare IT systems 65
5.2.2.2 High implementation and maintenance costs of quality management systems 65
5.2.3 OPPORTUNITIES 66
5.2.3.1 Integration with patient-generated health data (PGHD) 66
5.2.3.2 Voice and NLP for quality documentation 66
5.2.4 CHALLENGES 67
5.2.4.1 Data privacy and security concerns 67
5.2.4.2 Standardization of quality measures & data models 69
5.2.4.3 Limited skilled workforce & training gaps 69
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 70
5.4 INDUSTRY TRENDS 71
5.4.1 AI-DRIVEN PREDICTIVE ANALYTICS 71
5.4.2 INTEGRATION OF CLOUD-BASED QUALITY MANAGEMENT SOLUTIONS 72
5.4.3 EMPHASIS ON PATIENT-CENTERED CARE 72
5.4.4 REGULATORY COMPLIANCE AND RISK MANAGEMENT 72
5.4.5 CROSS-INDUSTRY COLLABORATION FOR INNOVATION 72
5.5 PRICING ANALYSIS 72
5.5.1 INDICATIVE PRICING OF HEALTHCARE QUALITY MANAGEMENT (QMS) SOLUTIONS, BY KEY PLAYER (2024) 73
5.5.2 INDICATIVE PRICING OF HEALTHCARE QUALITY MANAGEMENT (QMS) SOLUTIONS, BY REGION (2024) 74
5.5.3 PRICING MODELS (QUALITATIVE) 75
5.6 VALUE CHAIN ANALYSIS 76
5.6.1 PRODUCT DESIGN & DEVELOPMENT 77
5.6.2 SYSTEM INTEGRATION & WORKFLOW CUSTOMIZATION 77
5.6.3 IMPLEMENTATION 78
5.6.4 QUALITY ANALYTICS & REPORTING INSIGHTS 78
5.6.5 POST-SALES SERVICES 78
5.7 ECOSYSTEM ANALYSIS 78
5.8 INVESTMENT & FUNDING SCENARIO 81
5.9 TECHNOLOGY ANALYSIS 81
5.9.1 KEY TECHNOLOGIES 81
5.9.1.1 Quality measurement & reporting platforms 81
5.9.1.2 Performance & benchmarking analytics tools 82
5.9.1.3 Business intelligence (BI) & advanced analytics 82
5.9.2 COMPLEMENTARY TECHNOLOGIES 82
5.9.2.1 Interoperability/Health information exchange (HIE)/FHIR APIs 82
5.9.2.2 Telehealth & remote patient monitoring (RPM) 82
5.9.2.3 Data integration/Enterprise data warehouses & master data management 83
5.9.3 ADJACENT TECHNOLOGIES 83
5.9.3.1 Patient engagement platforms & portals (PROs) 83
5.9.3.2 Clinical documentation improvement (CDI) & coding/RCM systems 83
5.9.3.3 Automation & ambient clinician support (RPA, Voice/AI Scribing) 83
5.10 PATENT ANALYSIS 84
5.11 KEY CONFERENCES & EVENTS, 2025–2026 86
5.12 CASE STUDY ANALYSIS 87
5.12.1 CASE STUDY 1: DRIVING COST SAVINGS AND CARE QUALITY THROUGH UNIFIED DATA AND ANALYTICS 87
5.12.2 CASE STUDY 2: BOOSTING ACCURACY AND COMPLIANCE WITH AUTOMATED QUALITY REPORTING 87
5.12.3 CASE STUDY 3: IMPROVING CARE HOME COMPLIANCE AND OPERATIONAL EFFICIENCY THROUGH AUTOMATED QUALITY MANAGEMENT 88
5.13 REGULATORY ANALYSIS 88
5.13.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 89
5.13.2 REGULATORY LANDSCAPE 91
5.13.2.1 North America 91
5.13.2.2 Europe 92
5.13.2.3 Asia Pacific 92
5.13.2.4 Middle East & Africa 93
5.13.2.5 Latin America 93
5.14 PORTER’S FIVE FORCES ANALYSIS 94
5.14.1 BARGAINING POWER OF SUPPLIERS 95
5.14.2 BARGAINING POWER OF BUYERS 95
5.14.3 THREAT OF NEW ENTRANTS 96
5.14.4 THREAT OF SUBSTITUTES 96
5.14.5 INTENSITY OF COMPETITIVE RIVALRY 96
5.15 KEY STAKEHOLDERS & BUYING CRITERIA 96
5.15.1 KEY STAKEHOLDERS IN BUYING PROCESS 97
5.15.2 BUYING CRITERIA 98
5.16 UNMET NEEDS ANALYSIS 98
5.16.1 CURRENT UNMET NEEDS 98
5.16.2 END-USER EXPECTATIONS 100
5.17 BUSINESS MODEL ANALYSIS 101
5.17.1 SUBSCRIPTION-BASED (SAAS) MODEL 101
5.17.2 LICENSING & PERPETUAL SOFTWARE MODEL 101
5.17.3 PAY-PER-USE/TRANSACTION-BASED MODEL 101
5.17.4 ANALYTICS & BENCHMARKING SERVICES MODEL 101
5.17.5 QUALITY TRANSFORMATION & CONSULTING MODEL 101
5.18 IMPACT OF AI/GEN AI ON HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET 102
5.18.1 INTRODUCTION 102
5.18.2 MARKET POTENTIAL OF AI/GEN AI IN HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET 103
5.18.3 CASE STUDIES RELATED TO AI/GEN AI IMPLEMENTATION 104
5.18.3.1 Transforming healthcare quality management (QMS) with AI-powered virtual care platforms 104
5.18.4 IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS 105
5.18.4.1 Patient engagement solutions 105
5.18.4.2 Population health management 105
5.18.4.3 Patient safety software 106
5.18.5 USER READINESS AND IMPACT ASSESSMENT 106
5.18.5.1 User readiness 106
5.18.5.1.1 User A: Hospitals 106
5.18.5.1.2 User B: Outpatient & ambulatory care centers 106
5.18.5.2 Impact assessment 107
5.18.5.2.1 User A: Hospitals 107
5.18.5.2.2 User B: Outpatient & ambulatory care centers 107
5.19 IMPACT OF 2025 US TARIFFS ON HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET 108
5.19.1 INTRODUCTION 108
5.19.2 KEY TARIFF RATES 108
5.19.3 PRICE IMPACT ANALYSIS 109
5.19.4 IMPACT ON COUNTRY/REGION 109
5.19.4.1 US 109
5.19.4.2 Europe 110
5.19.4.3 Asia Pacific 110
5.19.5 IMPACT ON END-USE INDUSTRIES 110
5.19.5.1 Healthcare providers 110
5.19.5.2 Healthcare payers 111
6 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY OFFERING 112
6.1 INTRODUCTION 113
6.2 SOFTWARE 113
6.2.1 INTEGRATED SUITES 114
6.2.1.1 Increasing need for platforms to manage quality across entire care continuum to drive demand for integrated suites 114
6.2.2 POINT SOLUTIONS 115
6.2.2.1 Growing need for targeted tools that address specific challenges without need for enterprise-wide deployment to drive market 115
6.3 SERVICES 116
6.3.1 IMPLEMENTATION & TRAINING 118
6.3.1.1 Structured deployment and workforce training associated with implementation & training services to boost market 118
6.3.2 SUPPORT SERVICES 118
6.3.2.1 Ongoing technical assistance ensuring reliable performance of healthcare quality management (QMS) systems to support growth 118
6.3.3 CONSULTING SERVICES 119
6.3.3.1 Benefits such as strategic advisory and process optimization to drive demand for consulting services 119
6.3.4 OTHER SERVICES 120
7 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY FUNCTION 121
7.1 INTRODUCTION 122
7.2 DOCUMENT MANAGEMENT 122
7.2.1 ADVANTAGES SUCH AS STANDARDIZED CLINICAL AND OPERATIONAL WORKFLOWS AND RELIABLE AUDIT TRAILS TO DRIVE DEMAND 122
7.3 RISK MANAGEMENT 123
7.3.1 RISING ADOPTION OF RISK MANAGEMENT SOLUTIONS FOR IMPROVING PATIENT SAFETY AND COMPLIANCE TO DRIVE GROWTH 123
7.4 AUDIT MANAGEMENT 124
7.4.1 GROWING ADOPTION OF AUDIT MANAGEMENT SYSTEMS TO ENHANCE OPERATIONAL EFFICIENCY TO SUPPORT MARKET 124
7.5 CAPA & NONCONFORMANCE MANAGEMENT 125
7.5.1 GROWING NEED FOR CAPA & NONCONFORMANCE MANAGEMENT TO ENHANCE HEALTHCARE QUALITY AND COMPLIANCE TO FUEL GROWTH 125
7.6 CHANGE MANAGEMENT 126
7.6.1 RISING ADOPTION OF CHANGE MANAGEMENT SOLUTIONS TO STRENGTHEN COMPLIANCE AND QUALITY TO BOOST MARKET 126
7.7 COMPLAINT MANAGEMENT 127
7.7.1 GROWING USE OF COMPLAINT MANAGEMENT SYSTEMS TO STRENGTHEN PATIENT SAFETY AND REGULATORY COMPLIANCE TO PROPEL MARKET 127
7.8 TRAINING MANAGEMENT 128
7.8.1 STRENGTHENING WORKFORCE READINESS WITH TRAINING MANAGEMENT TOOLS TO CONTRIBUTE TO MARKET GROWTH 128
7.9 OTHER FUNCTIONS 129
8 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY USE CASE 131
8.1 INTRODUCTION 132
8.2 QUALITY REPORTING 132
8.2.1 ADVANTAGES SUCH AS STRUCTURED COLLECTION AND ANALYSIS OF PHYSICIAN PERFORMANCE TO BOOST MARKET 132
8.3 BUSINESS INTELLIGENCE & ANALYTICS 133
8.3.1 DEPLOYMENT OF ADVANCED ANALYTICS TO STRENGTHEN EFFICIENCY AND ACCOUNTABILITY TO DRIVE GROWTH 133
8.4 CLINICAL RISK MANAGEMENT 134
8.4.1 ADOPTION OF CLINICAL RISK MANAGEMENT TO ENHANCE PATIENT SAFETY, CARE QUALITY, AND ORGANIZATIONAL RESILIENCE 134
8.5 PROVIDER PERFORMANCE MANAGEMENT 135
8.5.1 OPTIMIZING CLINICIAN AND NETWORK PERFORMANCE THROUGH DATA-DRIVEN QUALITY MANAGEMENT IN HEALTHCARE TO SUPPORT GROWTH 135
8.6 REGULATORY & ACCREDITATION COMPLIANCE 136
8.6.1 ENHANCING HEALTHCARE QUALITY THROUGH PROACTIVE REGULATORY AND ACCREDITATION COMPLIANCE MANAGEMENT TO DRIVE MARKET 136
8.7 PATIENT EXPERIENCE & ENGAGEMENT 137
8.7.1 ENHANCING PATIENT EXPERIENCE AND ENGAGEMENT TO STRENGTHEN CARE QUALITY AND OPERATIONAL PERFORMANCE TO PROPEL MARKET 137
9 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY END USER 139
9.1 INTRODUCTION 140
9.2 HEALTHCARE PROVIDERS 140
9.2.1 HOSPITALS 141
9.2.1.1 Growing implementation of standardized care protocols and compliance measures to drive demand 141
9.2.2 OUTPATIENT & AMBULATORY CARE CENTERS 143
9.2.2.1 Growing need to streamline workflows and improve patient access to boost market 143
9.2.3 PHYSICIAN & GROUP PRACTICES 143
9.2.3.1 Ability to enhance care coordination and performance tracking to drive adoption 143
9.2.4 LONG-TERM CARE & POST-ACUTE FACILITIES 144
9.2.4.1 Benefits such as optimized patient safety and operational efficiency to fuel growth 144
9.2.5 OTHER HEALTHCARE PROVIDERS 145
9.3 HEALTHCARE PAYERS 146
9.3.1 PUBLIC PAYERS 147
9.3.1.1 Leveraging data-driven insights to improve population health and ensure compliance to support growth 147
9.3.2 PRIVATE PAYERS 148
9.3.2.1 Ability of tools to track outcomes, identify care gaps, and optimize interventions to boost demand 148
10 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY REGION 149
10.1 INTRODUCTION 150
10.2 NORTH AMERICA 151
10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 152
10.2.2 US 156
10.2.2.1 US to dominate global market for healthcare quality management (QMS) 156
10.2.3 CANADA 160
10.2.3.1 Growing government support and digital health adoption to fuel market growth 160
10.3 EUROPE 164
10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 165
10.3.2 UK 169
10.3.2.1 Growing digital health infrastructure and clinical innovation to fuel market growth 169
10.3.3 GERMANY 173
10.3.3.1 Operational and regulatory challenges in Germany’s healthcare quality management (QMS) market to limit growth 173
10.3.4 FRANCE 176
10.3.4.1 National quality strategies and hospital modernization to fuel market adoption 176
10.3.5 ITALY 180
10.3.5.1 Challenges and regional disparities in Italy’s healthcare quality management (QMS) market to hinder growth 180
10.3.6 SPAIN 184
10.3.6.1 Value-based care reforms and digital reporting to drive Spain’s healthcare quality management (QMS) market 184
10.3.7 REST OF EUROPE 188
10.4 ASIA PACIFIC 192
10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 193
10.4.2 JAPAN 197
10.4.2.1 Integration of AI regulations to enhance healthcare quality management (QMS) in Japan 197
10.4.3 CHINA 201
10.4.3.1 Challenges and operational barriers in China’s healthcare quality management (QMS) market to limit growth 201
10.4.4 INDIA 205
10.4.4.1 Public health reforms and regulatory oversight to drive growth in India’s healthcare quality management (QMS) market 205
10.4.5 SOUTH KOREA 209
10.4.5.1 Digital transformation to drive healthcare quality management (QMS) market in South Korea 209
10.4.6 AUSTRALIA 213
10.4.6.1 Workforce shortages and varying levels of staff training to hinder market growth 213
10.4.7 REST OF ASIA PACIFIC 217
10.5 LATIN AMERICA 221
10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 221
10.5.2 BRAZIL 225
10.5.2.1 Brazil to dominate healthcare quality management (QMS) market in Latin America 225
10.5.3 MEXICO 229
10.5.3.1 Mexico to emerge as key healthcare quality management (QMS) market in Latin America 229
10.5.4 REST OF LATIN AMERICA 233
10.6 MIDDLE EAST & AFRICA 237
10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 238
10.6.2 GCC COUNTRIES 242
10.6.2.1 Saudi Arabia 247
10.6.2.1.1 Regulatory reforms and Vision 2030 investments to support market growth 247
10.6.2.2 UAE 251
10.6.2.2.1 Accreditation and patient safety initiatives to drive market growth 251
10.6.2.3 Rest of Gcc Countries 254
10.6.3 REST OF MIDDLE EAST & AFRICA 258
11 COMPETITIVE LANDSCAPE 263
11.1 OVERVIEW 263
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 263
11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET 263
11.3 REVENUE ANALYSIS, 2020–2024 265
11.4 MARKET SHARE ANALYSIS, 2024 266
11.5 BRAND/PRODUCT COMPARISON 269
11.6 COMPANY VALUATION & FINANCIAL METRICS 270
11.6.1 FINANCIAL METRICS 270
11.6.2 COMPANY VALUATION 270
11.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 270
11.7.1 STARS 271
11.7.2 EMERGING LEADERS 271
11.7.3 PERVASIVE PLAYERS 271
11.7.4 PARTICIPANTS 271
11.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 273
11.7.5.1 Company footprint 273
11.7.5.2 Region footprint 274
11.7.5.3 Offering footprint 275
11.7.5.4 Function footprint 276
11.7.5.5 Use case footprint 277
11.7.5.6 End-user footprint 278
11.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 279
11.8.1 PROGRESSIVE COMPANIES 279
11.8.2 RESPONSIVE COMPANIES 279
11.8.3 DYNAMIC COMPANIES 279
11.8.4 STARTING BLOCKS 279
11.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 281
11.8.5.1 Detailed list of key startups/SMEs 281
11.8.5.2 Competitive benchmarking of startups/SMEs 282
11.9 COMPETITIVE SCENARIO 283
11.9.1 PRODUCT LAUNCHES & ENHANCEMENTS 283
11.9.2 DEALS 284
11.9.3 OTHER DEVELOPMENTS 285
12 COMPANY PROFILES 286
12.1 KEY PLAYERS 286
12.1.1 NUANCE COMMUNICATIONS, INC. (MICROSOFT) 286
12.1.1.1 Business overview 286
12.1.1.2 Products & services offered 287
12.1.1.3 Recent developments 288
12.1.1.3.1 Deals 288
12.1.1.4 MnM view 288
12.1.1.4.1 Right to win 288
12.1.1.4.2 Strategic choices 289
12.1.1.4.3 Weaknesses & competitive threats 289
12.1.2 PREMIER INC. 290
12.1.2.1 Business overview 290
12.1.2.1.1 Products & services offered 291
12.1.2.2 Recent developments 292
12.1.2.2.1 Product enhancements 292
12.1.2.2.2 Deals 292
12.1.2.3 MnM view 293
12.1.2.3.1 Right to win 293
12.1.2.3.2 Strategic choices 293
12.1.2.3.3 Weaknesses & competitive threats 293
12.1.3 OPTUM, INC. (UNITEDHEALTH GROUP) 294
12.1.3.1 Business overview 294
12.1.3.2 Products & services offered 295
12.1.3.3 Recent developments 296
12.1.3.3.1 Product launches & enhancements 296
12.1.3.3.2 Deals 296
12.1.3.4 MnM view 297
12.1.3.4.1 Right to win 297
12.1.3.4.2 Strategic choices 297
12.1.3.4.3 Weaknesses & competitive threats 297
12.1.4 INTELEX TECHNOLOGIES (FORTIVE) 298
12.1.4.1 Business overview 298
12.1.4.2 Products & services offered 299
12.1.4.3 Recent developments 300
12.1.4.3.1 Product launches & enhancements 300
12.1.4.3.2 Expansions 300
12.1.4.4 MnM view 301
12.1.4.4.1 Right to win 301
12.1.4.4.2 Strategic choices 301
12.1.4.4.3 Weaknesses & competitive threats 301
12.1.5 DNV 302
12.1.5.1 Business overview 302
12.1.5.2 Products & services offered 303
12.1.5.3 Recent developments 304
12.1.5.3.1 Product launches 304
12.1.5.3.2 Deals 304
12.1.5.4 MnM view 304
12.1.5.4.1 Right to win 304
12.1.5.4.2 Strategic choices 305
12.1.5.4.3 Weaknesses & competitive threats 305
12.1.6 RLDATIX 306
12.1.6.1 Business overview 306
12.1.6.2 Products & services offered 306
12.1.6.3 Recent developments 307
12.1.6.3.1 Product launches & enhancements 307
12.1.6.3.2 Deals 307
12.1.6.3.3 Other developments 308
12.1.6.4 MnM view 308
12.1.6.4.1 Right to win 308
12.1.6.4.2 Strategic choices 308
12.1.6.4.3 Weaknesses & competitive threats 308
12.1.7 RISKONNECT, INC. 309
12.1.7.1 Business overview 309
12.1.7.2 Products & services offered 309
12.1.7.3 Recent developments 310
12.1.7.3.1 Product enhancements 310
12.1.7.3.2 Deals 310
12.1.8 HCI 312
12.1.8.1 Business overview 312
12.1.8.2 Products & services offered 312
12.1.8.3 Recent developments 313
12.1.8.3.1 Product launches 313
12.1.8.3.2 Other developments 313
12.1.9 IDEAGEN 314
12.1.9.1 Business overview 314
12.1.9.2 Products & services offered 314
12.1.9.3 Recent developments 315
12.1.9.3.1 Product launches 315
12.1.9.3.2 Deals 315
12.1.10 MEDISOLV, INC. 316
12.1.10.1 Business overview 316
12.1.10.2 Products & services offered 316
12.1.10.3 Recent developments 317
12.1.10.3.1 Product approvals & enhancements 317
12.1.10.3.2 Deals 318
12.1.11 VĀLENZ HEALTH 319
12.1.11.1 Business overview 319
12.1.11.2 Products & services offered 319
12.1.11.3 Recent developments 320
12.1.11.3.1 Product launches 320
12.1.11.3.2 Deals 320
12.1.12 ODITEK SOLUTIONS 321
12.1.12.1 Business overview 321
12.1.12.2 Products & services offered 322
12.1.13 THE PATIENT SAFETY COMPANY (TPSC) 323
12.1.13.1 Business overview 323
12.1.13.2 Products & services offered 323
12.1.13.3 Recent developments 324
12.1.13.3.1 Product enhancements 324
12.1.14 MORCARE 325
12.1.14.1 Business overview 325
12.1.14.2 Products & services offered 325
12.1.15 YOUCOMPLY, LTD. (VICLARITY) 327
12.1.15.1 Business overview 327
12.1.15.2 Products & services offered 327
12.1.15.3 Recent developments 328
12.1.15.3.1 Product launches & enhancements 328
12.1.16 SIMPLERQMS 329
12.1.16.1 Business overview 329
12.1.16.2 Products & services offered 329
12.1.17 NAVEX GLOBAL, INC. (GOLDMAN SACHS) 330
12.1.17.1 Business overview 330
12.1.17.2 Products & services offered 331
12.1.17.3 Recent developments 332
12.1.17.3.1 Product enhancements 332
12.1.17.3.2 Deals 332
12.1.18 PROVIDERTRUST 333
12.1.18.1 Business overview 333
12.1.18.2 Products & services offered 333
12.1.18.3 Recent developments 334
12.1.18.3.1 Product launches 334
12.1.18.3.2 Deals 334
12.1.19 MEDTRAINER 335
12.1.19.1 Business overview 335
12.1.19.2 Products & services offered 335
12.1.19.3 Recent developments 336
12.1.19.3.1 Product launches 336
12.1.19.3.2 Deals 336
12.1.19.3.3 Other developments 336
12.2 OTHER PLAYERS 337
12.2.1 OKKALA SOLUTIONS PRIVATE LIMITED 337
12.2.2 SAFEQUAL 338
12.2.3 EFFIVITY TECHNOLOGIES, INC. 339
12.2.4 TITLE21 HEALTH SOLUTIONS 340
12.2.5 MEDBLAZE (INFINI) 341
12.2.6 ETASKPRO 342
12.2.7 QUALITYZE 343
12.2.8 KARMINN CONSULTANCY NETWORK 344
12.2.9 MEG 345
13 APPENDIX 346
13.1 DISCUSSION GUIDE 346
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 351
13.3 CUSTOMIZATION OPTIONS 353
13.4 RELATED REPORTS 353
13.5 AUTHOR DETAILS 354
LIST OF TABLES
TABLE 1 RISK ASSESSMENT: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET 50
TABLE 2 HEALTHCARE QUALITY MANAGEMENT (QMS): IMPACT ANALYSIS OF MARKET DYNAMICS 60
TABLE 3 US: INTEROPERABILITY FREQUENCY AMONG NON-FEDERAL ACUTE CARE HOSPITALS, BY HOSPITAL CHARACTERISTIC (2023) 63
TABLE 4 QMS REQUIREMENTS 64
TABLE 5 INDICATIVE PRICING OF HEALTHCARE QUALITY MANAGEMENT (QMS) SOLUTIONS, BY KEY PLAYER (2024) 74
TABLE 6 INDICATIVE PRICING OF HEALTHCARE QUALITY MANAGEMENT (QMS) SOLUTIONS, BY REGION (2024) 75
TABLE 7 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET: ROLE OF COMPANIES IN ECOSYSTEM 80
TABLE 8 JURISDICTION ANALYSIS OF TOP APPLICANT COUNTRIES FOR HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET (2025) 84
TABLE 9 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET: DETAILED LIST OF MAJOR CONFERENCES & EVENTS, 2025–2026 86
TABLE 10 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 89
TABLE 11 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 90
TABLE 12 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 90
TABLE 13 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 91
TABLE 14 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 91
TABLE 15 REGULATORY SCENARIO OF NORTH AMERICA 91
TABLE 16 REGULATORY SCENARIO OF EUROPE 92
TABLE 17 REGULATORY SCENARIO OF ASIA PACIFIC 92
TABLE 18 REGULATORY SCENARIO OF MIDDLE EAST & AFRICA 93
TABLE 19 REGULATORY SCENARIO OF LATIN AMERICA 93
TABLE 20 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET: PORTER’S FIVE FORCES ANALYSIS 94
TABLE 21 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END USER (%) 97
TABLE 22 KEY BUYING CRITERIA FOR END USERS 98
TABLE 23 UNMET NEEDS IN HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET 99
TABLE 24 END-USER EXPECTATIONS IN HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET 100
TABLE 25 US-ADJUSTED RECIPROCAL TARIFF RATES 108
TABLE 26 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY OFFERING,
2023–2030 (USD MILLION) 113
TABLE 27 HEALTHCARE QUALITY MANAGEMENT (QMS) SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 114
TABLE 28 HEALTHCARE QUALITY MANAGEMENT (QMS) SOFTWARE MARKET, BY REGION, 2023–2030 (USD MILLION) 114
TABLE 29 INTEGRATED SUITES OFFERED BY MAJOR PLAYERS 115
TABLE 30 HEALTHCARE QUALITY MANAGEMENT (QMS) SOFTWARE MARKET FOR INTEGRATED SUITES, BY REGION, 2023–2030 (USD MILLION) 115
TABLE 31 POINT SOLUTIONS OFFERED BY MAJOR PLAYERS 116
TABLE 32 HEALTHCARE QUALITY MANAGEMENT (QMS) SOFTWARE MARKET FOR BY POINT SOLUTIONS, BY REGION, 2023–2030 (USD MILLION) 116
TABLE 33 HEALTHCARE QUALITY MANAGEMENT (QMS) SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 117
TABLE 34 HEALTHCARE QUALITY MANAGEMENT (QMS) SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 117
TABLE 35 HEALTHCARE QUALITY MANAGEMENT (QMS) SERVICES MARKET FOR IMPLEMENTATION & TRAINING SERVICES, BY REGION, 2023–2030 (USD MILLION) 118
TABLE 36 HEALTHCARE QUALITY MANAGEMENT (QMS) SERVICES MARKET FOR SUPPORT SERVICES, BY REGION, 2023–2030 (USD MILLION) 119
TABLE 37 HEALTHCARE QUALITY MANAGEMENT (QMS) SERVICES MARKET FOR CONSULTING SERVICES, BY REGION, 2023–2030 (USD MILLION) 120
TABLE 38 HEALTHCARE QUALITY MANAGEMENT (QMS) SERVICES MARKET FOR OTHER SERVICES, BY REGION, 2023–2030 (USD MILLION) 120
TABLE 39 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY FUNCTION,
2023–2030 (USD MILLION) 122
TABLE 40 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR DOCUMENT MANAGEMENT, BY REGION, 2023–2030 (USD MILLION) 123
TABLE 41 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR RISK MANAGEMENT, BY REGION, 2023–2030 (USD MILLION) 124
TABLE 42 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR AUDIT MANAGEMENT, BY REGION, 2023–2030 (USD MILLION) 125
TABLE 43 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR CAPA & NONCONFORMANCE MANAGEMENT, BY REGION, 2023–2030 (USD MILLION) 126
TABLE 44 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR CHANGE MANAGEMENT, BY REGION, 2023–2030 (USD MILLION) 127
TABLE 45 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR COMPLAINT MANAGEMENT, BY REGION, 2023–2030 (USD MILLION) 128
TABLE 46 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR TRAINING MANAGEMENT, BY REGION, 2023–2030 (USD MILLION) 129
TABLE 47 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR OTHER FUNCTIONS,
BY REGION, 2023–2030 (USD MILLION) 130
TABLE 48 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY USE CASE,
2023–2030 (USD MILLION) 132
TABLE 49 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR PHYSICIAN QUALITY REPORTING, BY REGION, 2023–2030 (USD MILLION) 133
TABLE 50 BUSINESS INTELLIGENCE & ANALYTICS SOLUTIONS OFFERED BY MAJOR PLAYERS 134
TABLE 51 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR BUSINESS INTELLIGENCE & ANALYTICS, BY REGION, 2023–2030 (USD MILLION) 134
TABLE 52 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR CLINICAL RISK MANAGEMENT, BY REGION, 2023–2030 (USD MILLION) 135
TABLE 53 PROVIDER PERFORMANCE MANAGEMENT SOLUTIONS OFFERED BY MAJOR PLAYERS 136
TABLE 54 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR PROVIDER PERFORMANCE MANAGEMENT, BY REGION, 2023–2030 (USD MILLION) 136
TABLE 55 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR REGULATORY & ACCREDITATION COMPLIANCE, BY REGION, 2023–2030 (USD MILLION) 137
TABLE 56 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR PATIENT EXPERIENCE & ENGAGEMENT, BY REGION, 2023–2030 (USD MILLION) 138
TABLE 57 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY END USER,
2023–2030 (USD MILLION) 140
TABLE 58 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 141
TABLE 59 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR HEALTHCARE PROVIDERS, BY REGION, 2023–2030 (USD MILLION) 141
TABLE 60 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR HOSPITALS, BY REGION, 2023–2030 (USD MILLION) 142
TABLE 61 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR OUTPATIENT & AMBULATORY CARE CENTERS, BY REGION, 2023–2030 (USD MILLION) 143
TABLE 62 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR PHYSICIAN & GROUP PRACTICES, BY REGION, 2023–2030 (USD MILLION) 144
TABLE 63 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR LONG-TERM CARE & POST-ACUTE FACILITIES, BY REGION, 2023–2030 (USD MILLION) 145
TABLE 64 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR OTHER HEALTHCARE PROVIDERS, BY REGION, 2023–2030 (USD MILLION) 145
TABLE 65 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2023–2030 (USD MILLION) 146
TABLE 66 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR HEALTHCARE PAYERS, BY REGION, 2023–2030 (USD MILLION) 147
TABLE 67 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR PUBLIC PAYERS,
BY REGION, 2023–2030 (USD MILLION) 147
TABLE 68 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR PRIVATE PAYERS,
BY REGION, 2023–2030 (USD MILLION) 148
TABLE 69 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY REGION,
2023–2030 (USD MILLION) 150
TABLE 70 NORTH AMERICA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 153
TABLE 71 NORTH AMERICA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET,
BY OFFERING, 2023–2030 (USD MILLION) 153
TABLE 72 NORTH AMERICA: HEALTHCARE QUALITY MANAGEMENT (QMS) SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 153
TABLE 73 NORTH AMERICA: HEALTHCARE QUALITY MANAGEMENT (QMS) SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 154
TABLE 74 NORTH AMERICA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET,
BY FUNCTION, 2023–2030 (USD MILLION) 154
TABLE 75 NORTH AMERICA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY USE CASE, 2023–2030 (USD MILLION) 155
TABLE 76 NORTH AMERICA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY END USER, 2023–2030 (USD MILLION) 155
TABLE 77 NORTH AMERICA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 156
TABLE 78 NORTH AMERICA: HEALTHCARE QUALITY MANAGEMENT (QMS) FOR HEALTHCARE PAYERS, BY TYPE, 2023–2030 (USD MILLION) 156
TABLE 79 US: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY OFFERING,
2023–2030 (USD MILLION) 157
TABLE 80 US: HEALTHCARE QUALITY MANAGEMENT (QMS) SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 157
TABLE 81 US: HEALTHCARE QUALITY MANAGEMENT (QMS) SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 158
TABLE 82 US: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY FUNCTION,
2023–2030 (USD MILLION) 158
TABLE 83 US: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY USE CASE,
2023–2030 (USD MILLION) 159
TABLE 84 US: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY END USER,
2023–2030 (USD MILLION) 159
TABLE 85 US: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 160
TABLE 86 US: HEALTHCARE QUALITY MANAGEMENT (QMS) FOR HEALTHCARE PAYERS,
BY TYPE, 2023–2030 (USD MILLION) 160
TABLE 87 CANADA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY OFFERING, 2023–2030 (USD MILLION) 161
TABLE 88 CANADA: HEALTHCARE QUALITY MANAGEMENT (QMS) SOFTWARE MARKET,
BY TYPE, 2023–2030 (USD MILLION) 161
TABLE 89 CANADA: HEALTHCARE QUALITY MANAGEMENT (QMS) SERVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 162
TABLE 90 CANADA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 162
TABLE 91 CANADA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY USE CASE, 2023–2030 (USD MILLION) 163
TABLE 92 CANADA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY END USER, 2023–2030 (USD MILLION) 163
TABLE 93 CANADA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 164
TABLE 94 CANADA: HEALTHCARE QUALITY MANAGEMENT (QMS) FOR HEALTHCARE PAYERS, BY TYPE, 2023–2030 (USD MILLION) 164
TABLE 95 EUROPE: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 165
TABLE 96 EUROPE: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY OFFERING, 2023–2030 (USD MILLION) 166
TABLE 97 EUROPE: HEALTHCARE QUALITY MANAGEMENT (QMS) SOFTWARE MARKET,
BY TYPE, 2023–2030 (USD MILLION) 166
TABLE 98 EUROPE: HEALTHCARE QUALITY MANAGEMENT (QMS) SERVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 166
TABLE 99 EUROPE: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 167
TABLE 100 EUROPE: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY USE CASE, 2023–2030 (USD MILLION) 167
TABLE 101 EUROPE: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY END USER, 2023–2030 (USD MILLION) 168
TABLE 102 EUROPE: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 168
TABLE 103 EUROPE: HEALTHCARE QUALITY MANAGEMENT (QMS) FOR HEALTHCARE PAYERS, BY TYPE, 2023–2030 (USD MILLION) 168
TABLE 104 UK: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY OFFERING,
2023–2030 (USD MILLION) 169
TABLE 105 UK: HEALTHCARE QUALITY MANAGEMENT (QMS) SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 170
TABLE 106 UK: HEALTHCARE QUALITY MANAGEMENT (QMS) SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 170
TABLE 107 UK: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY FUNCTION,
2023–2030 (USD MILLION) 171
TABLE 108 UK: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY USE CASE,
2023–2030 (USD MILLION) 171
TABLE 109 UK: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY END USER,
2023–2030 (USD MILLION) 172
TABLE 110 UK: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 172
TABLE 111 UK: HEALTHCARE QUALITY MANAGEMENT (QMS) FOR HEALTHCARE PAYERS,
BY TYPE, 2023–2030 (USD MILLION) 172
TABLE 112 GERMANY: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY OFFERING, 2023–2030 (USD MILLION) 173
TABLE 113 GERMANY: HEALTHCARE QUALITY MANAGEMENT (QMS) SOFTWARE MARKET,
BY TYPE, 2023–2030 (USD MILLION) 173
TABLE 114 GERMANY: HEALTHCARE QUALITY MANAGEMENT (QMS) SERVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 174
TABLE 115 GERMANY: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 174
TABLE 116 GERMANY: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY USE CASE, 2023–2030 (USD MILLION) 175
TABLE 117 GERMANY: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY END USER, 2023–2030 (USD MILLION) 175
TABLE 118 GERMANY: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 176
TABLE 119 GERMANY: HEALTHCARE QUALITY MANAGEMENT (QMS) FOR HEALTHCARE PAYERS, BY TYPE, 2023–2030 (USD MILLION) 176
TABLE 120 FRANCE: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY OFFERING, 2023–2030 (USD MILLION) 177
TABLE 121 FRANCE: HEALTHCARE QUALITY MANAGEMENT (QMS) SOFTWARE MARKET,
BY TYPE, 2023–2030 (USD MILLION) 177
TABLE 122 FRANCE: HEALTHCARE QUALITY MANAGEMENT (QMS) SERVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 178
TABLE 123 FRANCE: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 178
TABLE 124 FRANCE: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY USE CASE, 2023–2030 (USD MILLION) 179
TABLE 125 FRANCE: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY END USER, 2023–2030 (USD MILLION) 179
TABLE 126 FRANCE: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 180
TABLE 127 FRANCE: HEALTHCARE QUALITY MANAGEMENT (QMS) FOR HEALTHCARE PAYERS, BY TYPE, 2023–2030 (USD MILLION) 180
TABLE 128 ITALY: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY OFFERING, 2023–2030 (USD MILLION) 181
TABLE 129 ITALY: HEALTHCARE QUALITY MANAGEMENT (QMS) SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 181
TABLE 130 ITALY: HEALTHCARE QUALITY MANAGEMENT (QMS) SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 182
TABLE 131 ITALY: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 182
TABLE 132 ITALY: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY USE CASE, 2023–2030 (USD MILLION) 183
TABLE 133 ITALY: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY END USER, 2023–2030 (USD MILLION) 183
TABLE 134 ITALY: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 184
TABLE 135 ITALY: HEALTHCARE QUALITY MANAGEMENT (QMS) FOR HEALTHCARE PAYERS,
BY TYPE, 2023–2030 (USD MILLION) 184
TABLE 136 SPAIN: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY OFFERING, 2023–2030 (USD MILLION) 185
TABLE 137 SPAIN: HEALTHCARE QUALITY MANAGEMENT (QMS) SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 185
TABLE 138 SPAIN: HEALTHCARE QUALITY MANAGEMENT (QMS) SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 186
TABLE 139 SPAIN: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 186
TABLE 140 SPAIN: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY USE CASE, 2023–2030 (USD MILLION) 187
TABLE 141 SPAIN: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY END USER, 2023–2030 (USD MILLION) 187
TABLE 142 SPAIN: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 188
TABLE 143 SPAIN: HEALTHCARE QUALITY MANAGEMENT (QMS) FOR HEALTHCARE PAYERS,
BY TYPE, 2023–2030 (USD MILLION) 188
TABLE 144 REST OF EUROPE: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET,
BY OFFERING, 2023–2030 (USD MILLION) 189
TABLE 145 REST OF EUROPE: HEALTHCARE QUALITY MANAGEMENT (QMS) SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 189
TABLE 146 REST OF EUROPE: HEALTHCARE QUALITY MANAGEMENT (QMS) SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 190
TABLE 147 REST OF EUROPE: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET,
BY FUNCTION, 2023–2030 (USD MILLION) 190
TABLE 148 REST OF EUROPE: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY USE CASE, 2023–2030 (USD MILLION) 191
TABLE 149 REST OF EUROPE: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY END USER, 2023–2030 (USD MILLION) 191
TABLE 150 REST OF EUROPE: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 192
TABLE 151 REST OF EUROPE: HEALTHCARE QUALITY MANAGEMENT (QMS) FOR HEALTHCARE PAYERS, BY TYPE, 2023–2030 (USD MILLION) 192
TABLE 152 ASIA PACIFIC: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 194
TABLE 153 ASIA PACIFIC: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY OFFERING, 2023–2030 (USD MILLION) 194
TABLE 154 ASIA PACIFIC: HEALTHCARE QUALITY MANAGEMENT (QMS) SOFTWARE MARKET,
BY TYPE, 2023–2030 (USD MILLION) 194
TABLE 155 ASIA PACIFIC: HEALTHCARE QUALITY MANAGEMENT (QMS) SERVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 195
TABLE 156 ASIA PACIFIC: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 195
TABLE 157 ASIA PACIFIC: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY USE CASE, 2023–2030 (USD MILLION) 196
TABLE 158 ASIA PACIFIC: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY END USER, 2023–2030 (USD MILLION) 196
TABLE 159 ASIA PACIFIC: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 197
TABLE 160 ASIA PACIFIC: HEALTHCARE QUALITY MANAGEMENT (QMS) FOR HEALTHCARE PAYERS, BY TYPE, 2023–2030 (USD MILLION) 197
TABLE 161 JAPAN: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY OFFERING, 2023–2030 (USD MILLION) 198
TABLE 162 JAPAN: HEALTHCARE QUALITY MANAGEMENT (QMS) SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 198
TABLE 163 JAPAN: HEALTHCARE QUALITY MANAGEMENT (QMS) SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 199
TABLE 164 JAPAN: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 199
TABLE 165 JAPAN: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY USE CASE, 2023–2030 (USD MILLION) 200
TABLE 166 JAPAN: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY END USER, 2023–2030 (USD MILLION) 200
TABLE 167 JAPAN: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 201
TABLE 168 JAPAN: HEALTHCARE QUALITY MANAGEMENT (QMS) FOR HEALTHCARE PAYERS,
BY TYPE, 2023–2030 (USD MILLION) 201
TABLE 169 CHINA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY OFFERING, 2023–2030 (USD MILLION) 202
TABLE 170 CHINA: HEALTHCARE QUALITY MANAGEMENT (QMS) SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 202
TABLE 171 CHINA: HEALTHCARE QUALITY MANAGEMENT (QMS) SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 203
TABLE 172 CHINA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 203
TABLE 173 CHINA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY USE CASE, 2023–2030 (USD MILLION) 204
TABLE 174 CHINA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY END USER, 2023–2030 (USD MILLION) 204
TABLE 175 CHINA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 205
TABLE 176 CHINA: HEALTHCARE QUALITY MANAGEMENT (QMS) FOR HEALTHCARE PAYERS,
BY TYPE, 2023–2030 (USD MILLION) 205
TABLE 177 INDIA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY OFFERING, 2023–2030 (USD MILLION) 206
TABLE 178 INDIA: HEALTHCARE QUALITY MANAGEMENT (QMS) SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 206
TABLE 179 INDIA: HEALTHCARE QUALITY MANAGEMENT (QMS) SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 207
TABLE 180 INDIA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 207
TABLE 181 INDIA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY USE CASE, 2023–2030 (USD MILLION) 208
TABLE 182 INDIA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY END USER, 2023–2030 (USD MILLION) 208
TABLE 183 INDIA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 209
TABLE 184 INDIA: HEALTHCARE QUALITY MANAGEMENT (QMS) FOR HEALTHCARE PAYERS,
BY TYPE, 2023–2030 (USD MILLION) 209
TABLE 185 SOUTH KOREA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET,
BY OFFERING, 2023–2030 (USD MILLION) 210
TABLE 186 SOUTH KOREA: HEALTHCARE QUALITY MANAGEMENT (QMS) SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 210
TABLE 187 SOUTH KOREA: HEALTHCARE QUALITY MANAGEMENT (QMS) SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 211
TABLE 188 SOUTH KOREA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET,
BY FUNCTION, 2023–2030 (USD MILLION) 211
TABLE 189 SOUTH KOREA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY USE CASE, 2023–2030 (USD MILLION) 212
TABLE 190 SOUTH KOREA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY END USER, 2023–2030 (USD MILLION) 212
TABLE 191 SOUTH KOREA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 213
TABLE 192 SOUTH KOREA: HEALTHCARE QUALITY MANAGEMENT (QMS) FOR HEALTHCARE PAYERS, BY TYPE, 2023–2030 (USD MILLION) 213
TABLE 193 AUSTRALIA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY OFFERING, 2023–2030 (USD MILLION) 214
TABLE 194 AUSTRALIA: HEALTHCARE QUALITY MANAGEMENT (QMS) SOFTWARE MARKET,
BY TYPE, 2023–2030 (USD MILLION) 214
TABLE 195 AUSTRALIA: HEALTHCARE QUALITY MANAGEMENT (QMS) SERVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 215
TABLE 196 AUSTRALIA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 215
TABLE 197 AUSTRALIA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY USE CASE, 2023–2030 (USD MILLION) 216
TABLE 198 AUSTRALIA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY END USER, 2023–2030 (USD MILLION) 216
TABLE 199 AUSTRALIA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 217
TABLE 200 AUSTRALIA: HEALTHCARE QUALITY MANAGEMENT (QMS) FOR HEALTHCARE PAYERS, BY TYPE, 2023–2030 (USD MILLION) 217
TABLE 201 REST OF ASIA PACIFIC: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET,
BY OFFERING, 2023–2030 (USD MILLION) 218
TABLE 202 REST OF ASIA PACIFIC: HEALTHCARE QUALITY MANAGEMENT (QMS) SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 218
TABLE 203 REST OF ASIA PACIFIC: HEALTHCARE QUALITY MANAGEMENT (QMS) SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 218
TABLE 204 REST OF ASIA PACIFIC: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET,
BY FUNCTION, 2023–2030 (USD MILLION) 219
TABLE 205 REST OF ASIA PACIFIC: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET,
BY USE CASE, 2023–2030 (USD MILLION) 219
TABLE 206 REST OF ASIA PACIFIC: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET,
BY END USER, 2023–2030 (USD MILLION) 220
TABLE 207 REST OF ASIA PACIFIC: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 220
TABLE 208 REST OF ASIA PACIFIC: HEALTHCARE QUALITY MANAGEMENT (QMS) FOR HEALTHCARE PAYERS, BY TYPE, 2023–2030 (USD MILLION) 220
TABLE 209 LATIN AMERICA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 222
TABLE 210 LATIN AMERICA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET,
BY OFFERING, 2023–2030 (USD MILLION) 222
TABLE 211 LATIN AMERICA: HEALTHCARE QUALITY MANAGEMENT (QMS) SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 222
TABLE 212 LATIN AMERICA: HEALTHCARE QUALITY MANAGEMENT (QMS) SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 223
TABLE 213 LATIN AMERICA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET,
BY FUNCTION, 2023–2030 (USD MILLION) 223
TABLE 214 LATIN AMERICA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY USE CASE, 2023–2030 (USD MILLION) 224
TABLE 215 LATIN AMERICA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY END USER, 2023–2030 (USD MILLION) 224
TABLE 216 LATIN AMERICA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 225
TABLE 217 LATIN AMERICA: HEALTHCARE QUALITY MANAGEMENT (QMS) FOR HEALTHCARE PAYERS, BY TYPE, 2023–2030 (USD MILLION) 225
TABLE 218 BRAZIL: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY OFFERING, 2023–2030 (USD MILLION) 226
TABLE 219 BRAZIL: HEALTHCARE QUALITY MANAGEMENT (QMS) SOFTWARE MARKET,
BY TYPE, 2023–2030 (USD MILLION) 226
TABLE 220 BRAZIL: HEALTHCARE QUALITY MANAGEMENT (QMS) SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 227
TABLE 221 BRAZIL: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 227
TABLE 222 BRAZIL: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY USE CASE, 2023–2030 (USD MILLION) 228
TABLE 223 BRAZIL: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY END USER, 2023–2030 (USD MILLION) 228
TABLE 224 BRAZIL: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 229
TABLE 225 BRAZIL: HEALTHCARE QUALITY MANAGEMENT (QMS) FOR HEALTHCARE PAYERS, BY TYPE, 2023–2030 (USD MILLION) 229
TABLE 226 MEXICO: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY OFFERING, 2023–2030 (USD MILLION) 230
TABLE 227 MEXICO: HEALTHCARE QUALITY MANAGEMENT (QMS) SOFTWARE MARKET,
BY TYPE, 2023–2030 (USD MILLION) 230
TABLE 228 MEXICO: HEALTHCARE QUALITY MANAGEMENT (QMS) SERVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 231
TABLE 229 MEXICO: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 231
TABLE 230 MEXICO: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY USE CASE, 2023–2030 (USD MILLION) 232
TABLE 231 MEXICO: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY END USER, 2023–2030 (USD MILLION) 232
TABLE 232 MEXICO: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 233
TABLE 233 MEXICO: HEALTHCARE QUALITY MANAGEMENT (QMS) FOR HEALTHCARE PAYERS, BY TYPE, 2023–2030 (USD MILLION) 233
TABLE 234 REST OF LATIN AMERICA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY OFFERING, 2023–2030 (USD MILLION) 234
TABLE 235 REST OF LATIN AMERICA: HEALTHCARE QUALITY MANAGEMENT (QMS) SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 234
TABLE 236 REST OF LATIN AMERICA: HEALTHCARE QUALITY MANAGEMENT (QMS) SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 235
TABLE 237 REST OF LATIN AMERICA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 235
TABLE 238 REST OF LATIN AMERICA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY USE CASE, 2023–2030 (USD MILLION) 236
TABLE 239 REST OF LATIN AMERICA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY END USER, 2023–2030 (USD MILLION) 236
TABLE 240 REST OF LATIN AMERICA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 237
TABLE 241 REST OF LATIN AMERICA: HEALTHCARE QUALITY MANAGEMENT (QMS) FOR HEALTHCARE PAYERS, BY TYPE, 2023–2030 (USD MILLION) 237
TABLE 242 MIDDLE EAST & AFRICA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET,
BY REGION, 2023–2030 (USD MILLION) 239
TABLE 243 MIDDLE EAST & AFRICA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET,
BY OFFERING, 2023–2030 (USD MILLION) 239
TABLE 244 MIDDLE EAST & AFRICA: HEALTHCARE QUALITY MANAGEMENT (QMS) SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 239
TABLE 245 MIDDLE EAST & AFRICA: HEALTHCARE QUALITY MANAGEMENT (QMS) SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 240
TABLE 246 MIDDLE EAST & AFRICA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET,
BY FUNCTION, 2023–2030 (USD MILLION) 240
TABLE 247 MIDDLE EAST & AFRICA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET,
BY USE CASE, 2023–2030 (USD MILLION) 241
TABLE 248 MIDDLE EAST & AFRICA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET,
BY END USER, 2023–2030 (USD MILLION) 241
TABLE 249 MIDDLE EAST & AFRICA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 242
TABLE 250 MIDDLE EAST & AFRICA: HEALTHCARE QUALITY MANAGEMENT (QMS) FOR HEALTHCARE PAYERS, BY TYPE, 2023–2030 (USD MILLION) 242
TABLE 251 GCC COUNTRIES: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 243
TABLE 252 GCC COUNTRIES: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET,
BY OFFERING, 2023–2030 (USD MILLION) 243
TABLE 253 GCC COUNTRIES: HEALTHCARE QUALITY MANAGEMENT (QMS) SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 244
TABLE 254 GCC COUNTRIES: HEALTHCARE QUALITY MANAGEMENT (QMS) SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 244
TABLE 255 GCC COUNTRIES: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET,
BY FUNCTION, 2023–2030 (USD MILLION) 245
TABLE 256 GCC COUNTRIES: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY USE CASE, 2023–2030 (USD MILLION) 245
TABLE 257 GCC COUNTRIES: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY END USER, 2023–2030 (USD MILLION) 246
TABLE 258 GCC COUNTRIES: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 246
TABLE 259 GCC COUNTRIES: HEALTHCARE QUALITY MANAGEMENT (QMS) FOR HEALTHCARE PAYERS, BY TYPE, 2023–2030 (USD MILLION) 246
TABLE 260 SAUDI ARABIA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET,
BY OFFERING, 2023–2030 (USD MILLION) 247
TABLE 261 SAUDI ARABIA: HEALTHCARE QUALITY MANAGEMENT (QMS) SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 248
TABLE 262 SAUDI ARABIA: HEALTHCARE QUALITY MANAGEMENT (QMS) SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 248
TABLE 263 SAUDI ARABIA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET,
BY FUNCTION, 2023–2030 (USD MILLION) 249
TABLE 264 SAUDI ARABIA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY USE CASE, 2023–2030 (USD MILLION) 249
TABLE 265 SAUDI ARABIA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY END USER, 2023–2030 (USD MILLION) 250
TABLE 266 SAUDI ARABIA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 250
TABLE 267 SAUDI ARABIA: HEALTHCARE QUALITY MANAGEMENT (QMS) FOR HEALTHCARE PAYERS, BY TYPE, 2023–2030 (USD MILLION) 250
TABLE 268 UAE: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY OFFERING,
2023–2030 (USD MILLION) 251
TABLE 269 UAE: HEALTHCARE QUALITY MANAGEMENT (QMS) SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 251
TABLE 270 UAE: HEALTHCARE QUALITY MANAGEMENT (QMS) SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 252
TABLE 271 UAE: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY FUNCTION,
2023–2030 (USD MILLION) 252
TABLE 272 UAE: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY USE CASE,
2023–2030 (USD MILLION) 253
TABLE 273 UAE: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY END USER,
2023–2030 (USD MILLION) 253
TABLE 274 UAE: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 254
TABLE 275 UAE: HEALTHCARE QUALITY MANAGEMENT (QMS) FOR HEALTHCARE PAYERS,
BY TYPE, 2023–2030 (USD MILLION) 254
TABLE 276 REST OF GCC COUNTRIES: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY OFFERING, 2023–2030 (USD MILLION) 255
TABLE 277 REST OF GCC COUNTRIES: HEALTHCARE QUALITY MANAGEMENT (QMS) SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 255
TABLE 278 REST OF GCC COUNTRIES: HEALTHCARE QUALITY MANAGEMENT (QMS) SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 256
TABLE 279 REST OF GCC COUNTRIES: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 256
TABLE 280 REST OF GCC COUNTRIES: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY USE CASE, 2023–2030 (USD MILLION) 257
TABLE 281 REST OF GCC COUNTRIES: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY END USER, 2023–2030 (USD MILLION) 257
TABLE 282 REST OF GCC COUNTRIES: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 258
TABLE 283 REST OF GCC COUNTRIES: HEALTHCARE QUALITY MANAGEMENT (QMS) FOR HEALTHCARE PAYERS, BY TYPE, 2023–2030 (USD MILLION) 258
TABLE 284 REST OF MIDDLE EAST & AFRICA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY OFFERING, 2023–2030 (USD MILLION) 259
TABLE 285 REST OF MIDDLE EAST & AFRICA: HEALTHCARE QUALITY MANAGEMENT (QMS) SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 259
TABLE 286 REST OF MIDDLE EAST & AFRICA: HEALTHCARE QUALITY MANAGEMENT (QMS) SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 260
TABLE 287 REST OF MIDDLE EAST & AFRICA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 260
TABLE 288 REST OF MIDDLE EAST & AFRICA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY USE CASE, 2023–2030 (USD MILLION) 261
TABLE 289 REST OF MIDDLE EAST & AFRICA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY END USER, 2023–2030 (USD MILLION) 261
TABLE 290 REST OF MIDDLE EAST & AFRICA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 262
TABLE 291 REST OF MIDDLE EAST & AFRICA: HEALTHCARE QUALITY MANAGEMENT (QMS) FOR HEALTHCARE PAYERS, BY TYPE, 2023–2030 (USD MILLION) 262
TABLE 292 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN HEALTHCARE QUALITY MANAGEMENT (QMS), JANUARY 2022–SEPTEMBER 2025 263
TABLE 293 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET: DEGREE OF COMPETITION 267
TABLE 294 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET: REGION FOOTPRINT 274
TABLE 295 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET: OFFERING FOOTPRINT 275
TABLE 296 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET: FUNCTION FOOTPRINT 276
TABLE 297 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET: USE CASE FOOTPRINT 277
TABLE 298 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET: END-USER FOOTPRINT 278
TABLE 299 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS 281
TABLE 300 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS, BY REGION 282
TABLE 301 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS, BY FUNCTION 282
TABLE 302 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2022–SEPTEMBER 2025 283
TABLE 303 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET: DEALS,
JANUARY 2022–SEPTEMBER 2025 284
TABLE 304 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET: OTHER DEVELOPMENTS, JANUARY 2022–SEPTEMBER 2025 285
TABLE 305 NUANCE COMMUNICATIONS, INC. (MICROSOFT): COMPANY OVERVIEW 286
TABLE 306 NUANCE COMMUNICATIONS, INC. (MICROSOFT): PRODUCTS & SERVICES OFFERED 287
TABLE 307 NUANCE COMMUNICATIONS, INC. (MICROSOFT): DEALS,
JANUARY 2022–SEPTEMBER 2025 288
TABLE 308 PREMIER INC.: COMPANY OVERVIEW 290
TABLE 309 PREMIER INC.: PRODUCTS & SERVICES OFFERED 291
TABLE 310 PREMIER INC.: PRODUCT ENHANCEMENTS, JANUARY 2022–SEPTEMBER 2025 292
TABLE 311 PREMIER INC.: DEALS, JANUARY 2022–SEPTEMBER 2025 292
TABLE 312 OPTUM, INC. (UNITEDHEALTH GROUP): COMPANY OVERVIEW 294
TABLE 313 OPTUM, INC. (UNITEDHEALTH GROUP): PRODUCTS & SERVICES OFFERED 295
TABLE 314 OPTUM, INC. (UNITEDHEALTH GROUP): PRODUCT LAUNCHES & ENHANCEMENTS, ENHANCEMENT, JANUARY 2022–SEPTEMBER 2025 296
TABLE 315 OPTUM, INC. (UNITEDHEALTH GROUP): DEALS, JANUARY 2022–SEPTEMBER 2025 296
TABLE 316 INTELEX TECHNOLOGIES (FORTIVE): COMPANY OVERVIEW 298
TABLE 317 INTELEX TECHNOLOGIES (FORTIVE): PRODUCTS & SERVICES OFFERED 299
TABLE 318 INTELEX TECHNOLOGIES (FORTIVE): PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2022–SEPTEMBER 2025 300
TABLE 319 INTELEX TECHNOLOGIES (FORTIVE): EXPANSIONS,
JANUARY 2022–SEPTEMBER 2025 300
TABLE 320 DNV: COMPANY OVERVIEW 302
TABLE 321 DNV: PRODUCTS & SERVICES OFFERED 303
TABLE 322 DNV: PRODUCT LAUNCHES, JANUARY 2022–SEPTEMBER 2025 304
TABLE 323 DNV: DEALS, JANUARY 2022–SEPTEMBER 2025 304
TABLE 324 RLDATIX: COMPANY OVERVIEW 306
TABLE 325 RLDATIX: PRODUCTS & SERVICES OFFERED 306
TABLE 326 RLDATIX: PRODUCT LAUNCHES & ENHANCEMENTS,
JANUARY 2022–SEPTEMBER 2025 307
TABLE 327 RLDATIX: DEALS, JANUARY 2022–SEPTEMBER 2025 307
TABLE 328 RLDATIX: OTHER DEVELOPMENTS, JANUARY 2022–SEPTEMBER 2025 308
TABLE 329 RISKONNECT, INC.: COMPANY OVERVIEW 309
TABLE 330 RISKONNECT, INC.: PRODUCTS & SERVICES OFFERED 309
TABLE 331 RISKONNECT, INC.: PRODUCT ENHANCEMENTS,
JANUARY 2022–SEPTEMBER 2025 310
TABLE 332 RISKONNECT, INC.: DEALS, JANUARY 2022–SEPTEMBER 2025 310
TABLE 333 HCI: COMPANY OVERVIEW 312
TABLE 334 HCI: PRODUCTS & SERVICES OFFERED 312
TABLE 335 HCI: PRODUCT LAUNCHES, JANUARY 2022–SEPTEMBER 2025 313
TABLE 336 HCI: OTHER DEVELOPMENTS, JANUARY 2022–SEPTEMBER 2025 313
TABLE 337 IDEAGEN: COMPANY OVERVIEW 314
TABLE 338 IDEAGEN: PRODUCTS & SERVICES OFFERED 314
TABLE 339 IDEAGEN: PRODUCT LAUNCHES, JANUARY 2022–SEPTEMBER 2025 315
TABLE 340 IDEAGEN: DEALS, JANUARY 2022–SEPTEMBER 2025 315
TABLE 341 MEDISOLV, INC.: COMPANY OVERVIEW 316
TABLE 342 MEDISOLV, INC.: PRODUCTS & SERVICES OFFERED 316
TABLE 343 MEDISOLV, INC.: PRODUCT APPROVALS & ENHANCEMENTS,
JANUARY 2022–SEPTEMBER 2025 317
TABLE 344 MEDISOLV, INC.: DEALS, JANUARY 2022–SEPTEMBER 2025 318
TABLE 345 VĀLENZ HEALTH: COMPANY OVERVIEW 319
TABLE 346 VĀLENZ HEALTH: PRODUCTS & SERVICES OFFERED 319
TABLE 347 VĀLENZ HEALTH: PRODUCT LAUNCHES, JANUARY 2022–SEPTEMBER 2025 320
TABLE 348 VĀLENZ HEALTH: DEALS, JANUARY 2022–SEPTEMBER 2025 320
TABLE 349 ODITEK SOLUTIONS: COMPANY OVERVIEW 321
TABLE 350 ODITEK SOLUTIONS: PRODUCTS & SERVICES OFFERED 322
TABLE 351 THE PATIENT SAFETY COMPANY (TPSC): COMPANY OVERVIEW 323
TABLE 352 THE PATIENT SAFETY COMPANY (TPSC): PRODUCTS & SERVICES OFFERED 323
TABLE 353 THE PATIENT SAFETY COMPANY (TPSC): PRODUCT ENHANCEMENTS,
JANUARY 2022–SEPTEMBER 2025 324
TABLE 354 MORCARE: COMPANY OVERVIEW 325
TABLE 355 MORCARE: PRODUCTS & SERVICES OFFERED 325
TABLE 356 YOUCOMPLY, LTD. (VICLARITY): COMPANY OVERVIEW 327
TABLE 357 YOUCOMPLY, LTD. (VICLARITY): PRODUCTS & SERVICES OFFERED 327
TABLE 358 YOUCOMPLY, LTD. (VICLARITY): PRODUCT LAUNCHES & ENHANCEMENTS,
JANUARY 2022–SEPTEMBER 2025 328
TABLE 359 SIMPLERQMS: COMPANY OVERVIEW 329
TABLE 360 SIMPLERQMS: PRODUCTS & SERVICES OFFERED 329
TABLE 361 NAVEX GLOBAL, INC. (GOLDMAN SACHS): COMPANY OVERVIEW 330
TABLE 362 NAVEX GLOBAL, INC. (GOLDMAN SACHS): PRODUCTS & SERVICES OFFERED 331
TABLE 363 NAVEX GLOBAL, INC. (GOLDMAN SACHS): PRODUCT ENHANCEMENTS,
JANUARY 2022–SEPTEMBER 2025 332
TABLE 364 NAVEX GLOBAL, INC. (GOLDMAN SACHS): DEALS,
JANUARY 2022–SEPTEMBER 2025 332
TABLE 365 PROVIDERTRUST: COMPANY OVERVIEW 333
TABLE 366 PROVIDERTRUST: PRODUCTS & SERVICES OFFERED 333
TABLE 367 PROVIDERTRUST: PRODUCT LAUNCHES, JANUARY 2022–SEPTEMBER 2025 334
TABLE 368 PROVIDERTRUST: DEALS, JANUARY 2022–SEPTEMBER 2025 334
TABLE 369 MEDTRAINER: COMPANY OVERVIEW 335
TABLE 370 MEDTRAINER: PRODUCTS & SERVICES OFFERED 335
TABLE 371 MEDTRAINER: PRODUCT LAUNCHES, JANUARY 2022–SEPTEMBER 2025 336
TABLE 372 MEDTRAINER: DEALS, JANUARY 2022–SEPTEMBER 2025 336
TABLE 373 MEDTRAINER: OTHER DEVELOPMENTS, JANUARY 2021–SEPTEMBER 2025 336
TABLE 374 OKKALA SOLUTIONS PRIVATE LIMITED: COMPANY OVERVIEW 337
TABLE 375 SAFEQUAL: COMPANY OVERVIEW 338
TABLE 376 EFFIVITY TECHNOLOGIES, INC.: COMPANY OVERVIEW 339
TABLE 377 TITLE21 HEALTH SOLUTIONS: COMPANY OVERVIEW 340
TABLE 378 MEDBLAZE (INFINI): COMPANY OVERVIEW 341
TABLE 379 ETASKPRO: COMPANY OVERVIEW 342
TABLE 380 QUALITYZE: COMPANY OVERVIEW 343
TABLE 381 KARMINN CONSULTANCY NETWORK: COMPANY OVERVIEW 344
TABLE 382 MEG: COMPANY OVERVIEW 345
LIST OF FIGURES
FIGURE 1 HEALTHCARE QUALITY MANAGEMENT MARKET SEGMENTATION & REGIONAL SCOPE 35
FIGURE 2 RESEARCH DESIGN 40
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,
AND REGION 43
FIGURE 4 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 45
FIGURE 5 BOTTOM-UP APPROACH 46
FIGURE 6 TOP-DOWN APPROACH 46
FIGURE 7 CAGR PROJECTIONS FROM ANALYSIS OF MARKET DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF HEALTHCARE QUALITY MANAGEMENT (QMS) INDUSTRY 47
FIGURE 8 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 48
FIGURE 9 DATA TRIANGULATION METHODOLOGY 49
FIGURE 10 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY OFFERING,
2025 VS. 2030 (USD MILLION) 51
FIGURE 11 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY FUNCTION,
2025 VS. 2030 (USD MILLION) 52
FIGURE 12 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY USE CASE,
2025 VS. 2030 (USD MILLION) 53
FIGURE 13 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY END USER,
2025 VS. 2030 (USD MILLION) 53
FIGURE 14 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET: GEOGRAPHIC SNAPSHOT 54
FIGURE 15 GROWING REGULATORY REQUIREMENTS AND GOVERNMENT INITIATIVES TO DRIVE MARKET 56
FIGURE 16 SOFTWARE SEGMENT TO ACCOUNT FOR LARGEST MARKET SHARE IN 2025 57
FIGURE 17 INDIA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 57
FIGURE 18 ASIA PACIFIC TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 58
FIGURE 19 DEVELOPING ECONOMIES TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD 58
FIGURE 20 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 59
FIGURE 21 US: ENGAGEMENT WITH AND FREQUENCY OF INTEROPERABLE EXCHANGE AMONG NON-FEDERAL ACUTE CARE HOSPITALS, 2018–2023 63
FIGURE 22 PATIENT-GENERATED HEALTH DATA USE CASE 66
FIGURE 23 HEALTHCARE DATA BREACHES (2009–2025) 68
FIGURE 24 INDIVIDUALS AFFECTED BY HEALTHCARE DATA BREACHES (2009–2025) 68
FIGURE 25 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 71
FIGURE 26 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET: VALUE CHAIN ANALYSIS 77
FIGURE 27 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET: ECOSYSTEM ANALYSIS 79
FIGURE 28 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET: INVESTMENT & FUNDING SCENARIO 81
FIGURE 29 JURISDICTION ANALYSIS OF TOP APPLICANT COUNTRIES FOR HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET (2025) 84
FIGURE 30 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET: TOP PATENT OWNERS/PATENTING TRENDS, 2015–2025 85
FIGURE 31 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET: PORTER’S FIVE FORCES ANALYSIS 95
FIGURE 32 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END USER 97
FIGURE 33 KEY BUYING CRITERIA FOR END USERS 98
FIGURE 34 MARKET POTENTIAL OF AI/GEN AI ON HEALTHCARE QUALITY MANAGEMENT (QMS) ACROSS INDUSTRIES 103
FIGURE 35 IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS 105
FIGURE 36 NUMBER OF US HOSPITALS, BY TYPE (2025) 142
FIGURE 37 US HEALTH INSURANCE INDUSTRY (DIRECT HALTH PREMIUM), 2024 146
FIGURE 38 NORTH AMERICA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET SNAPSHOT 152
FIGURE 39 ASIA PACIFIC: HEALTHCRE QUALITY MANAGEMENT (QMS) MARKET SNAPSHOT 193
FIGURE 40 REVENUE ANALYSIS OF KEY PLAYERS IN HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, 2020–2024 266
FIGURE 41 MARKET SHARE ANALYSIS OF KEY PLAYERS IN HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET (2024) 267
FIGURE 42 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 269
FIGURE 43 EV/EBITDA OF KEY VENDORS 270
FIGURE 44 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 270
FIGURE 45 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET: COMPANY EVALUATION QUADRANT (KEY PLAYERS), 2024 272
FIGURE 46 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET: COMPANY FOOTPRINT 273
FIGURE 47 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 280
FIGURE 48 NUANCE COMMUNICATIONS, INC. (MICROSOFT): COMPANY SNAPSHOT (2025) 287
FIGURE 49 PREMIER INC.: COMPANY SNAPSHOT (2025) 291
FIGURE 50 OPTUM, INC. (UNITEDHEALTH GROUP): COMPANY SNAPSHOT (2024) 295
FIGURE 51 INTELEX TECHNOLOGIES (FORTIVE): COMPANY SNAPSHOT (2024) 299
FIGURE 52 DNV: COMPANY SNAPSHOT (2024) 303
FIGURE 53 NAVEX GLOBAL, INC. (GOLDMAN SACHS): COMPANY SNAPSHOT (2024) 331
MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。
※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。
ライセンス別価格表
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
ライセンスタイプ1
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD4,950 | USD6,650 | USD8,150 | USD10,000 |
ライセンスタイプ2
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD7,150 | USD8,500 | USD9,650 | USD11,000 |
ライセンスタイプ3
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD8,150 | お問合せください | お問合せください | お問合せください |
ライセンスタイプ4
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD9,000 | USD10,500 | USD12,000 | USD13,500 |
ミニレポート ※定性調査にフォーカスした調査レポートです。詳細はお問合せください。
| シングルユーザ | コーポレート |
| USD 2,650 | USD 4,250 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
- ライセンス
- シングルユーザライセンス
- 1名のみレポートファイルのご利用が可能です。
- マルチユーザライセンス
- 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
- コーポレートライセンス
- 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
- エンタープライズサイトライセンス
- 特別ライセンスです。適用範囲についてはお問合せください。
- シングルユーザライセンス
- 納品形態
- Eメール
- 納期
- 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。
最新調査レポート
- 精密林業市場規模、シェア、動向、2030年までの世界予測 2025-11-05
- フィールドサービス管理市場規模、シェア、動向、2030年までの世界予測 2025-11-05
- 採血装置市場規模、シェア、動向、2030年までの世界予測 2025-11-04
- 車載半導体市場規模、シェア、動向、2030年までの世界予測 2025-11-04
- データセンターUPS市場規模、シェア、動向、2030年までの世界予測 2025-10-31